The research team, led by Zhi Xu, Yongqi Shao, Zhijun Zhang, and Yonggui Yuan, assembled a cohort of 721 patients diagnosed with major depressive disorder according to DSM-IV criteria, alongside 960 healthy controls. All participants were of Chinese ancestry, a detail that matters enormously in psychiatric genetics, where most large-scale genome-wide association studies have historically been conducted in European populations. Genetic differences between ancestry groups can distort risk predictions, so testing polygenic approaches in East Asian cohorts is an important step toward clinical tools that work globally.

Polygenic risk scores, or PRS, are built by summing the small effects of many single nucleotide polymorphisms across the genome, each weighted according to its association with the disease as estimated in a large external study. In this work, the researchers drew base statistics from the Psychiatric Genomics Consortium’s East Asian datasets for major depressive disorder and schizophrenia, and from BioBank Japan for insomnia and body mass index. The idea was to test not only whether a depression-specific score predicts depression, but whether genetically related traits — sleep disturbance and adiposity among them — carry detectable risk signal in the same individuals.

Before any scoring took place, the team applied stringent quality control using PLINK v1.90, filtering variants on criteria such as minor allele frequency and genotyping quality. They then used PRSice v2.3.5 with its PRSet function to generate optimized scores across a range of p-value thresholds, a standard technique that tunes how permissive the score is in including weakly associated variants. Statistical comparisons between patients and controls were carried out with independent two-sample t-tests or Mann-Whitney U tests in R v4.3.0, and logistic regression models adjusted for age, sex, and ancestry principal components quantified how well the scores discriminated case status.

The headline result was clear: the depression-specific polygenic risk score differed significantly between patients and controls, with p less than 0.001. The logistic prediction model built on this score was statistically significant, achieving an empirical p-value of 9.999 × 10⁻⁵, though the pseudo-R² of 2.1 percent underscores how modest the explanatory power remains. In plain terms, the genetic score carries real signal, but depression is shaped by far more than inherited common variants — environment, life stress, and gene-environment interplay all contribute, and no current PRS comes close to serving as a standalone diagnostic.

Perhaps more striking was what happened with the cross-phenotype scores. Models built from schizophrenia, insomnia, and body mass index statistics failed to reach statistical significance in this cohort. That null result is informative rather than disappointing. It suggests that, at least in this Chinese sample and with these particular base datasets, the shared genetic architecture between depression and those related traits is not strong enough to yield transferable predictive signal — a reminder that genetic correlations reported in European-ancestry studies do not always replicate cleanly across populations and phenotype definitions.

The study’s most innovative contribution lies in its pathway-based approach. Rather than treating the genome as an undifferentiated mass of variants, the researchers used Gene Ontology gene sets drawn from the Molecular Signatures Database to construct pathway-specific PRS — scores restricted to variants within genes belonging to defined biological functions. This yielded 16 significant pathway scores in the Biological Process category, 13 in Molecular Function, and 12 in Cellular Component. Notably, most of these pathway PRS models showed greater explanatory power than the single-phenotype whole-genome score, hinting that biological organization concentrates signal that is otherwise diluted across the full genome.

Among the prioritized pathways, the study highlighted genes involved in processes such as uridine diphosphate-glucuronosyltransferase activity, retinoic acid signaling, hypothalamic-pituitary-adrenal axis regulation, and endoplasmic reticulum function — biological themes with plausible connections to stress response, neurodevelopment, and cellular stress handling in depression. The authors are careful to frame these as statistically prioritized candidates for future functional investigation rather than confirmed causal mechanisms, which is the appropriate scientific posture at this stage.

Methodologically, the work demonstrates a template that other groups can follow: rigorous quality control, threshold optimization, covariate-adjusted regression, and pathway-level aggregation using established gene set resources. The pathway approach effectively performs a gene set analysis on top of polygenic scoring, trading some statistical breadth for biological interpretability. When a pathway-level score outperforms the genome-wide score, it suggests that the true signal is concentrated in coherent biological modules — a finding that can guide laboratory work toward specific molecular machinery rather than leaving researchers with a diffuse list of risk loci.

The limitations are worth stating plainly. A pseudo-R² of 2.1 percent means the depression PRS explains only a small fraction of case-control status, and the cross-phenotype null results temper expectations for borrowing signal from related traits in this population. Larger East Asian discovery cohorts will be needed to strengthen base statistics, and replication in independent Chinese samples will be essential before any clinical translation. Still, by validating the depression PRS in a non-European cohort and demonstrating that pathway-based scoring can extract more explanatory power than conventional single-phenotype scores, the study charts a practical route toward genetically informed risk stratification for one of psychiatry’s most burdensome disorders.

Subject of Research: Polygenic risk score analysis of major depressive disorder in a Chinese cohort using single-phenotype and Gene Ontology pathway-based approaches

Article Title: Polygenic risk score analysis for major depressive disorder in a Chinese cohort: single-phenotype and pathway-based approaches

Article References: Xu, Z., Shao, Y., Li, Y., Liu, R., Tang, H., Cai, Y., Dang, X., Sun, J., Zhang, B., Chen, B., Zhang, Z., & Yuan, Y. (2026). Polygenic risk score analysis for major depressive disorder in a Chinese cohort: single-phenotype and pathway-based approaches. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08589-7

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08589-7

Keywords: polygenic risk score, major depressive disorder, genetics, psychiatry, Gene Ontology, pathway analysis, Chinese cohort, GWAS, Psychiatric Genomics Consortium, BioBank Japan, logistic regression, depression risk